Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
NAD⁺ & NMN
Research brief

Long-term NMN in male and female mice: lifespan and healthspan effects

In mice, long-term NMN reduced frailty in both sexes; median lifespan rose 8.5% only in females, while males showed more physical activity and metabolic changes plus upregulated inflammatory pathways. [1]

Automatic summary · not editorially reviewed

The key findings

  1. In female mice, but not males, long-term NMN increased median lifespan by 8.5%. [1]

  2. In both sexes, NMN reduced frailty, associated with more Anaerotruncus colihominis. [1]

  3. In male mice, NMN increased physical activity and metabolic health but upregulated inflammatory pathways. [1]

The source at a glance

Study type / format
Preclinical mouse study (abstract)
Population / context
Male and female mice
Summary based on
Study abstract
Publication status
Preprint · peer-review status not confirmed
Original publication
September 21, 2026

NMN and lifespan in male and female mice

The abstract asks whether the NAD+ precursor nicotinamide mononucleotide (NMN) extends lifespan in mammals, noting this was previously unknown. The researchers gave mice long-term NMN and compared healthspan and lifespan in males and females. In females, but not males, NMN increased median lifespan by 8.5% and upregulated mitochondrial function markers in metabolic tissues. These are mouse results from an abstract; they do not show a lifespan benefit in humans.

Supporting source [1]

Frailty, gut bacterium and sex-specific changes

In both sexes, NMN reduced frailty, and this effect was associated with increased abundance of Anaerotruncus colihominis, a butyrate-producing gut bacterium. In males, but not females, NMN increased physical activity and boosted metabolic health, while also upregulating inflammatory pathways, likely due to sex-specific increased expression of NAD+ consumers including CD38. The abstract describes these as associations and likely explanations, not proven causes.

Supporting source [1]

What the mouse abstract can and cannot show

The authors conclude that the results highlight the potential of NAD+ boosters for treating age-related conditions. This is a proposed potential, not a demonstrated treatment. The abstract reports no sample sizes, follow-up duration, dosing or statistical details, and the full text was not reviewed. Because the work is in mice, the findings cannot be transferred directly to human lifespan or health.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Sample sizes, follow-up, dosing and statistics are not reported here. Mouse findings do not establish human lifespan or health benefits.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Long-term NMN treatment increases lifespan and healthspan in mice in a sex dependent manner

Kane A, Chellappa K, Schultz M, Carr A, Arnold M, Li J, Amorim J, Zheng M, Gao Y, Rich K, Lichter J, Dixon-McDougall T, O'Donnell C, Ibrahim N, Joshi N, Zambrano R, Thompson E, Ouyang S, Tyshkovskiy A, Diener C, Zhu D, Mitchell S, Griffin P, Tian X, Petty C, Conway R, Walsh K, Shelerud L, Duesing C, Mueller A, Li K, McNamara M, Shima R, Tobias-Wallingford H, Ross J, Coppotellii G, de Cabo R, Gladyshev V, Wu L, Yuji I, Gibbons S, Baur J, Rajman L, Sinclair D. · europepmc.org · September 21, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    NMN increased median lifespan by 8.5%
  2. Finding 2 ↑

    NMN reduced frailty
  3. Finding 3 ↑

    NMN increased physical activity and boosted metabolic

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…